Treatment With Oral Etoposide for Childhood Recurrent Ependymomas

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Etoposide: four decades of development of a topoisomerase II inhibitor

1998 • 907 citations

A randomized trial to evaluate the effect of schedule on the activity of etoposide in small-cell lung cancer.

1989 • 467 citations

Prolonged oral etoposide as second-line therapy for platinum-resistant and platinum-sensitive ovarian carcinoma: a Gynecologic Oncology Group study.

1998 • 393 citations

Intracranial ependymomas in children: A critical review of prognostic factors and a plea for cooperation

1998 • 190 citations

VP-16-213 monotherapy for remission induction of small cell lung cancer: a randomized trial using three dosage schedules.

1978 • 166 citations

Chronic daily administration of oral etoposide--a phase I trial.

1989 • 153 citations

Bioavailability of low-dose oral etoposide.

1993 • 147 citations

Response of recurrent medulloblastoma to low-dose oral etoposide.

1996 • 131 citations

Recurrent intracranial ependymomas in children survival, patterns of failure, and prognostic factors

1990 • 124 citations

Phase II study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma

1996 • 115 citations

Etoposide: Twenty years later

1995 • 105 citations

Phase II study of daily oral etoposide in children with recurrent brain tumors and other solid tumors

1997 • 104 citations

Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study

2004 • 93 citations

Salvage chemotherapy for recurrent spinal cord ependymona

2002 • 85 citations

Recurrent brainstem gliomas treated with oral VP-16

1993 • 73 citations

Recurrent chiasmatic-hypothalamic glioma treated with oral etoposide.

1995 • 67 citations

Multivariate Analysis of Clinical Prognostic Factors in Children with Intracranial Ependymomas

2004 • 60 citations

Changing patterns of care in the management of anemia.

1992 • 57 citations

Recurrent intracranial ependymoma in children: salvage therapy with oral etoposide

2001 • 55 citations

Ependymoma

2003 • 53 citations

Chronic oral VP-16 for recurrent medulloblastoma

1997 • 53 citations

Recurrent Supratentorial Malignant Gliomas in Children

1997 • 50 citations

Phase II study of 21 day schedule oral etoposide in children

1997 • 47 citations

Treatment of Non-Small-Cell Lung Cancer With Prolonged Oral Etoposide

1998 • 46 citations

High-dose chemotherapy in childhood brain tumours

1999 • 44 citations

Recurrent Cerebellar Gliomas: Salvage Therapy With Oral Etoposide

1997 • 32 citations

Clinical and pharmacokinetic study of oral etoposide in patients with AIDS-related Kaposi's sarcoma with no prior exposure to cytotoxic therapy.

1997 • 32 citations

Etoposide pharmacology.

1992 • 31 citations

Phase II Trial of Oral Etoposide in Recurrent or Refractory Endometrial Adenocarcinoma: A Southwest Oncology Group Study

1999 • 27 citations

Results of a phase II trial of combined chemotherapy for patients with diffuse malignant mesothelioma of the pleura

1999 • 24 citations

Daily Oral Etoposide in Patients With Heavily Pretreated Metastatic Breast Cancer

1998 • 23 citations

Low-Dose Oral Etoposide Monotherapy in Adult Langerhans Cell Histiocytosis

1998 • 16 citations

Phase II study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in metastatic malignant melanoma

1996 • 7 citations